Home » Topics » BioWorld

BioWorld
RSS

INNOVET TO LICENSE IMMUNE STIMULANT

Sep. 5, 1991

SMITHKLINE RAISES ANTE FOR VC FUND

Sep. 5, 1991

MARROW-TECH TO GRANT RIGHTS FOR SKIN2

Sep. 5, 1991

TEST PREDICTS PREMATURE BIRTHS

Sep. 5, 1991

UPJOHN ENHANCES HAIR GROWTH PRODUCT

Sep. 5, 1991

CLINICALS HELP CENTOXIN GET NOD

Sep. 5, 1991

FDA REBUFFS XOMA'S E5

Sep. 5, 1991

CHIRON CLAIMS PATENT IS KEY TO FACTOR VIII:C

Sep. 4, 1991

WHAT'S AT STAKE IN FDA REVIEW

Sep. 4, 1991

HEAVY TRADING BEFORE SEPSIS SHOWDOWN

Sep. 4, 1991

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...